On-time Enrollment Feasibility


The upfront investment of time and medical expertise into each feasibility assessment underlies PSI’s patient enrollment success in clinical trials.

For the majority of studies, where competition for patients and complexity of design are leading characteristics, we apply our years of experience to determine the best sites and countries for each study.

We give every project a thorough assessment through our dedicated, full-time Feasibility Department.  Our dedicated professionals determine clinical trial feasibility for each of the following criterion:

  • Medical feasibility
  • Clinical feasibility
  • Logistical feasibility
  • Regulatory feasibility

With people located in 11 countries throughout North America, Europe, Asia, and Latin America being led by our team of internal medical doctors, laboratory experts, imaging specialists, logisticians, pharmacy and regulatory experts, PSI predicts accurate dates for the enrollment of the first and last patients.

In recent years, our specialists have conducted over 2,000+ feasibility assessments for studies in 50+ countries.  These assessments cover, but are not restricted to, evaluation of the target population availability and factors that limit it, standards of care, competitive studies, regulatory climates and the need to engage particular Key Opinion Leaders into the study.  We weigh all of these factors before making recommendations.

Our value-added feasibility assessments for regional or global programs provide our sponsors with the best choice of sites and geography, ensuring predictable and accurate enrollment projections.

Please contact PSI to learn how the accuracy of feasibility can help you achieve your study goals.

Can’t find what you’re looking for? Contact us


Clinical Innovation & Partnering World 2017
March 8-9, 2017
Visit the Site  
View More


Outstanding job PSI has done in accessing and providing us with requested source documents. With the thousands of emails zipping around each month, they never lose track of a single request; and are able to respond immediately to our questions. There are just not words enough to express our gratitude and thanks. OUTSTANDING JOB!"
Pharma consultant, USA, March 2016
The performance of the entire team thus far has been exemplary. They have consistently met the established timelines, thoughtfully navigated obstacles along the way, and have allowed us to start off to a successful “roll-over” beginning. The team has shown a commitment to teamwork and collaboration in their efforts."
From a pharma client, USA, March 2016
A fantastic accomplishment. Team work at its finest. Great job."
Clinical Scientific Director, USA, February 2016
Read More



Zug, Switzerland, 22 November 2016 – PSI CRO, a global full-service contract research organization, will present at the upcoming conference “Clinical Operations in Oncology Trials” on 29-30 November in Amsterdam, the Netherlands.
PSI’s Director of Feasibility Research and Patient Recruitment Services, Kasia Moscicka, will present on Targeted Feasibility in Oncology Trials … Read More »

Read More


  • This field is for validation purposes and should be left unchanged.